PharmacyCodes



Tizanidina [Inn-Spanish] en es it fr

Tizanidina [Inn-Spanish] Brand names, Tizanidina [Inn-Spanish] Analogs

Tizanidina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Tizanidina [Inn-Spanish] Chemical_Formula

C9H8ClN5S

Tizanidina [Inn-Spanish] RX_link

http://www.rxlist.com/cgi/generic/tizanidine.htm

Tizanidina [Inn-Spanish] fda sheet

Tizanidina_[Inn-Spanish] FDA

Tizanidina [Inn-Spanish] msds (material safety sheet)

Tizanidina [Inn-Spanish] Synthesis Reference

No information avaliable

Tizanidina [Inn-Spanish] Molecular Weight

253.712 g/mol

Tizanidina [Inn-Spanish] Melting Point

No information avaliable

Tizanidina [Inn-Spanish] H2O Solubility

No information avaliable

Tizanidina [Inn-Spanish] State

Solid

Tizanidina [Inn-Spanish] LogP

-1.591

Tizanidina [Inn-Spanish] Dosage Forms

Tablet

Tizanidina [Inn-Spanish] Indication

For the management of increased muscle tone associated with spasticity

Tizanidina [Inn-Spanish] Pharmacology

Tizanidine is a short-acting drug for the management of spasticity. Tizanidine is an agonist at a2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. In animal models, tizanidine has no direct effect on skeletal muscle fibers or the neuromuscular junction, and no major effect on monosynaptic spinal reflexes. The effects of tizanidine are greatest on polysynaptic pathways. The overall effect of these actions is thought to reduce facilitation of spinal motor neurons.

Tizanidina [Inn-Spanish] Absorption

No information avaliable

Tizanidina [Inn-Spanish] side effects and Toxicity

No information avaliable

Tizanidina [Inn-Spanish] Patient Information

No information avaliable

Tizanidina [Inn-Spanish] Organisms Affected

Humans and other mammals